Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Learning from Crisis: a Multicentre Study of Oncology Telemedicine Clinics Introduced During COVID-19.
J Cancer Educ. 2022 Dec;37(6):1861-1869. doi: 10.1007/s13187-021-02053-8. Epub 2021 Jul 2.
J Cancer Educ. 2022.
PMID: 34213751
Free PMC article.
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Newton C, Murali K, Ahmad A, Hockings H, Graham R, Liberale V, Sarker SJ, Ledermann J, Berney DM, Shamash J, Banerjee S, Stoneham S, Lockley M.
Newton C, et al. Among authors: hockings h.
Eur J Cancer. 2019 May;113:19-27. doi: 10.1016/j.ejca.2019.03.001. Epub 2019 Apr 4.
Eur J Cancer. 2019.
PMID: 30954883
Free PMC article.
Item in Clipboard
The role of MET in chemotherapy resistance.
Wood GE, Hockings H, Hilton DM, Kermorgant S.
Wood GE, et al. Among authors: hockings h.
Oncogene. 2021 Mar;40(11):1927-1941. doi: 10.1038/s41388-020-01577-5. Epub 2021 Feb 1.
Oncogene. 2021.
PMID: 33526881
Free PMC article.
Review.
Item in Clipboard
LiquidCNA: Tracking subclonal evolution from longitudinal liquid biopsies using somatic copy number alterations.
Lakatos E, Hockings H, Mossner M, Huang W, Lockley M, Graham TA.
Lakatos E, et al. Among authors: hockings h.
iScience. 2021 Jul 21;24(8):102889. doi: 10.1016/j.isci.2021.102889. eCollection 2021 Aug 20.
iScience. 2021.
PMID: 34401670
Free PMC article.
Item in Clipboard
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer.
Hoare JI, Hockings H, Saxena J, Silva VL, Haughey MJ, Wood GE, Nicolini F, Mirza H, McNeish IA, Huang W, Maniati E, Graham TA, Lockley M.
Hoare JI, et al. Among authors: hockings h.
Gynecol Oncol. 2022 Oct;167(1):96-106. doi: 10.1016/j.ygyno.2022.07.027. Epub 2022 Jul 30.
Gynecol Oncol. 2022.
PMID: 35918200
Free article.
Item in Clipboard
The role of PARP inhibitor combination therapy in ovarian cancer.
Hockings H, Miller RE.
Hockings H, et al.
Ther Adv Med Oncol. 2023 May 16;15:17588359231173183. doi: 10.1177/17588359231173183. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37215065
Free PMC article.
Review.
Item in Clipboard
Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer.
Hockings H, Lakatos E, Huang W, Mossner M, Khan MA, Metcalf S, Nicolini F, Smith K, Baker AM, Graham TA, Lockley M.
Hockings H, et al.
bioRxiv [Preprint]. 2023 Jul 25:2023.07.21.549688. doi: 10.1101/2023.07.21.549688.
bioRxiv. 2023.
PMID: 37546942
Free PMC article.
Preprint.
Item in Clipboard
Is oestrogen neuroprotective?
Agius M, Hockings H, Wilson C, Lane D.
Agius M, et al. Among authors: hockings h.
Psychiatr Danub. 2009 Sep;21 Suppl 1:120-7.
Psychiatr Danub. 2009.
PMID: 19789496
Review.
Item in Clipboard
Cite
Cite